YM
Yahya Muhieddine Portfolio
Invests via Eleva Capital SAS | Managed by Yahya Muhieddine
Invests via Eleva Capital SAS
Managed by Yahya Muhieddine
Automatically Tracked
Seasoned operator and investor focused on technology and financial services, Yahya Muhieddine combines multi-market operating experience with active angel and seed-stage investing. He has led startups through product-market fit and capital raises, advised growth-stage management teams, and participates in early-stage syndicates targeting fintech, SaaS and marketplaces across MENA and Europe. Market-facing strengths include capital formation, go-to-market strategy and corporate partnerships.
Seasoned operator and investor focused on technology and financial services, Yahya Muhieddine combines multi-market operating experience with active angel and seed-stage investing. He has led startups through product-market fit and capital raises, advised growth-stage management teams, and participates in early-stage syndicates targeting fintech, SaaS and marketplaces across MENA and Europe. Market-facing strengths include capital formation, go-to-market strategy and corporate partnerships.
Investment Philosophy & Strategy
Combines operator-led, thesis-driven early-stage investing with active portfolio support in fintech, SaaS and marketplace models across MENA and Europe. Focuses on seed and pre-seed opportunities where founder-market fit and scalable go-to-market motion are evident, deploying concentrated capital with reserved follow-on allocation. Investment decisions favor durable unit economics, partnership-driven distribution channels and defensible product propositions. Emphasizes rapid validation, capital formation expertise and board/advisor involvement to accelerate growth toward strategic exits or growth rounds.
Combines operator-led, thesis-driven early-stage investing with active portfolio support in fintech, SaaS and marketplace models across MENA and Europe. Focuses on seed and pre-seed opportunities where founder-market fit and scalable go-to-market motion are evident, deploying concentrated capital with reserved follow-on allocation. Investment decisions favor durable unit economics, partnership-driven distribution channels and defensible product propositions. Emphasizes rapid validation, capital formation expertise and board/advisor involvement to accelerate growth toward strategic exits or growth rounds.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
6.4%
Gain +1.14%
Monthly
0.47%
Yearly
5.84%
Drawdown
17.07%
$321.72M
Equity
Holdings
$321.72M
Investment
$308.73M
$27.87M
Profit +$5.17M
Realized
$14.88M
Unrealized
$12.99M
Dividends
$4.45M
Goals
Avg. 26.5% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
1.14%
Profit
$5.17M
Win %
62%
This Week
Compared To Last Week
Gain
1.64%
Profit
$5.17M
Win %
62%
This Month
Compared to last month
Gain
1.64%
Profit
$5.17M
Win %
62%
This Year
Compared to last year
Gain
-9.43%
Profit
-$34.93M
Win %
64%
AMZN Amazon.com Inc
+15.32%
+$582,872.24 
GOOGL Alphabet Inc
+6.73%
+$628,418.49 
ANET Arista Networks, Inc.
+5.46%
+$438,109.09 
NVDA NVIDIA Corporation
+2.93%
+$296,931.78 
BSX Boston Scientific Corporation
+1.59%
+$19,466.91 
ESPR Esperion Therapeutics Inc.
0%
$0 
TSMWF Taiwan Semiconductor Manufacturing Company Limited
0%
$0 H591
H5919C104
0%
$0 
EWTX Edgewise Therapeutics, Inc.
-6.54%
-$46,967.4 
VRDN Viridian Therapeutics Inc.
-4.92%
-$6,983.48 
SPOT Spotify Technology S.A.
-4.34%
-$61,549.02 
FENC Fennec Pharmaceuticals Inc.
-3.43%
-$18,099.56 
IRON Disc Medicine Inc.
-2.79%
-$11,304.15 
MLYS Mineralys Therapeutics, Inc.
-2.56%
-$11,444.27 
CGON CG Oncology, Inc.
-2.52%
-$15,251.75 
NAMS NewAmsterdam Pharma Co. N.V.
-2.35%
-$17,233.07 
ACHR Archer Aviation Inc.
-2.11%
-$2,153.4 
NFLX Netflix, Inc.
-2%
-$127,297.4 
AS Amer Sports, Inc.
-1.63%
-$176,292.58 
FCX Freeport-McMoRan Inc.
-1.28%
-$1,828.98 
CRH CRH plc
-1.03%
-$2.63M 
AQST Aquestive Therapeutics Inc.
-0.67%
-$68 
TMUS T-Mobile US, Inc.
-0.36%
-$9,038.47 
HOOD Robinhood Markets, Inc.
-0.05%
-$1,265 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 70 | Longs Won 39/70 55% | Profit Factor 4.19 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.67M |
| Average Win $938,402 | Best Trade (Aug 03) $12.24M | Sharpe Ratio -11.62 |
| Average Loss -$281,679.2 | Worst Trade (Aug 02) -$3.89M | Z-Score 1.45 (85.4%) |
| Commissions $0 | Avg. Trade Length 5m 1w | Expectancy $398,080.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 1,142 | 1,027 | 913 | 799 | 685 | 571 | 457 | 342 | 228 | 114 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| ACHR Archer Aviation Inc. | 21,534 | $111,331 | $99,917.76 | - | -$11,413.24 | -10.25% | -2.11% |
| AMZN Amazon.com Inc | 16,155 | $3.36M | $4.39M | - | $1.02M | 30.4% | +15.321% |
| ANET Arista Networks, Inc. | 46,957 | $6.54M | $8.47M | - | $1.93M | 29.42% | +5.456% |
| AQST Aquestive Therapeutics Inc. | 2,720 | $11,288 | $10,050.4 | - | -$1,237.6 | -10.96% | -0.672% |
| AS Amer Sports, Inc. | 298,802 | $10.45M | $10.61M | - | $164,405.6 | 1.57% | -1.634% |
| BSX Boston Scientific Corporation | 26,667 | $1.67M | $1.25M | - | -$427,205.09 | -25.53% | +1.587% |
| CGON CG Oncology, Inc. | 8,289 | $561,000 | $590,093.91 | - | $29,093.91 | 5.19% | -2.52% |
| CRH CRH plc | 2.65M | $248.12M | $252.25M | - | $4.13M | 1.66% | -1.031% |
| ESPR Esperion Therapeutics Inc. | 183,047 | $501,549 | $582,089.46 | - | $80,540.46 | 16.06% | 0.0 |
| EWTX Edgewise Therapeutics, Inc. | 17,460 | $549,990 | $670,987.8 | - | $120,997.8 | 22% | -6.542% |
| FCX Freeport-McMoRan Inc. | 2,258 | $132,725 | $141,418.54 | - | $8,693.54 | 6.55% | -1.277% |
| FENC Fennec Pharmaceuticals Inc. | 53,234 | $327,389 | $509,449.38 | - | $182,060.38 | 55.61% | -3.431% |
| GOOGL Alphabet Inc | 27,967 | $8.04M | $9.96M | - | $1.92M | 23.85% | +6.734% |
| H591 H5919C104 | 50,150 | $1.71M | $1.71M | - | - | - | 0.0 |
| HOOD Robinhood Markets, Inc. | 31,625 | $2.19M | $2.74M | - | $545,847 | 24.91% | -0.046% |
| IRON Disc Medicine Inc. | 5,115 | $327,053 | $393,855 | - | $66,802 | 20.43% | -2.79% |
| MLYS Mineralys Therapeutics, Inc. | 17,081 | $462,724 | $435,907.12 | - | -$26,816.88 | -5.8% | -2.558% |
| NAMS NewAmsterdam Pharma Co. N.V. | 25,721 | $823,329 | $714,786.59 | - | -$108,542.41 | -13.18% | -2.354% |
| NFLX Netflix, Inc. | 87,190 | $8.93M | $6.25M | - | -$2.67M | -29.95% | -1.995% |
| NVDA NVIDIA Corporation | 52,002 | $9.07M | $10.44M | - | $1.37M | 15.11% | +2.928% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Yahya Muhieddine?
The largest contributions to the portfolio's profits come from the following stocks: CRH plc - $7.31M, Bloom Energy Corporation - $2.49M, Alibaba Group Holding Limited SP ADR - $1.77M, NVIDIA Corporation - $1.2M, and Alphabet Inc - $1.16M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: MercadoLibre, Inc - $347,244.88, Apollo Global Management, Inc - $209,004.7, Otis Worldwide Corporation - $193,811.65, HubSpot, Inc - $144,348, and ServiceNow, Inc - $117,155.9. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Yahya Muhieddine's portfolio generate?
The portfolio generates substantial dividend income, with a total of $4.45M earned over time. The largest contributors to dividend income include CRH plc - $4.24M, AngloGold Ashanti plc - $85,499.04, Microsoft Corp - $23,341.95, T-Mobile US, Inc - $14,633.94, and Tapestry Inc - $13,979.6. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Yahya Muhieddine's monthly returns?
Yahya Muhieddine's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can Yahya Muhieddine's strategy be considered aggressive or moderate?
Yahya Muhieddine's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow Yahya Muhieddine's strategy?
Yahya Muhieddine's strategy may be suitable for beginners, but with some caution. While the overall approach is not overly complex, it still involves a certain level of risk and variability. Beginners should be prepared for occasional fluctuations and ensure they understand the strategy before trying to follow it.
